David Subías

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 3K citations · Full text

Medicine, Endocrinology, Pharmacology +14

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 629 citations · Full text

Medicine, Endocrinology, Nephrology +15

Serum Levels of TWEAK and Scavenger Receptor CD163 in Type 1 Diabetes Mellitus: Relationship with Cardiovascular Risk Factors. A Case-Control Study

Gemma Llauradó, José-Miguel González-Clemente, Elsa Maymó‐Masip et al. · PLoS ONE · 2012 · 50 citations · Full text

Medicine, Cardiology, Endocrinology +14

Decision Support in Diabetes Care: The Challenge of Supporting Patients in Their Daily Living Using a Mobile Glucose Predictor

Carmen Pérez-Gandía, Gema García-Sáez, David Subías et al. · Journal of Diabetes Science and Technology · 2018 · 37 citations · Full text

Computing, Biomedical Informatics, Health Informatics +17

Artificial Pancreas Using a Personalized Rule-Based Controller Achieves Overnight Normoglycemia in Patients with Type 1 Diabetes

Ismael Capel, Mercedes Rigla, Gema García-Sáez et al. · Diabetes Technology & Therapeutics · 2013 · 29 citations · Full text

Medicine, Endocrinology, Internal Medicine +17